Skip to main content
Log in

The norepinephrine transporter gene is a candidate gene for panic disorder

  • Biological Psychiatry - Original Article
  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Abstract

Panic disorder (PD) is an anxiety disorder characterized by recurrent panic attacks with a lifetime prevalence of 4.7%. Genetic factors are known to contribute to the development of the disorder. Several lines of evidence point towards a major role of the norepinephrine system in the pathogenesis of PD. The SLC6A2 gene is located on chromosome 16q12.2 and encodes the norepinephrine transporter (NET), responsible for the reuptake of norepinephrine into presynaptic nerve terminals. The aim of the present study was to analyze genetic variants located within the NET gene for association with PD. The case–control sample consisted of 449 patients with PD and 279 ethnically matched controls. All cases fulfilled the ICD-10 diagnostic criteria for PD. Genotyping was performed using the Sequenom platform (Sequenom, Inc, San Diego, USA). To test for allelic and haplotypic association, the PLINK software was used, and COMBASSOC was applied to test for gene-wise association. After quality control 29 single nucleotide polymorphisms (SNPs) spanning the gene-region were successfully analyzed. Seven SNPs located within the 5′ end of the gene were significantly associated with PD. Furthermore, the NET gene showed overall evidence for association with the disease (P = 0.000035). In conclusion, the present study indicates that NET could be a susceptibility gene for PD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Banaschewski T, Becker K, Scherag S, Franke B, Coghill D (2010) Molecular genetics of attention-deficit/hyperactivity disorder: an overview. Eur Child Adolesc Psychiatry 19(3):237–257

    Article  PubMed  Google Scholar 

  • Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265

    Article  PubMed  CAS  Google Scholar 

  • Bosker FJ, Hartman CA, Nolte IM, Prins BP, Terpstra P, Posthuma D, van VT, Willemsen G, Derijk RH, de Geus EJ, Hoogendijk WJ, Sullivan PF, Penninx BW, Boomsma DI, Snieder H, Nolen WA (2010) Poor replication of candidate genes for major depressive disorder using genome-wide association data. Mol Psychiatry [Epub ahead of print]

  • Bremner JD, Krystal JH, Southwick SM, Charney DS (1996) Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 23(1):39–51

    Article  PubMed  CAS  Google Scholar 

  • Charney DS, Heninger GR, Breier A (1984) Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder. Arch Gen Psychiatry 41(8):751–763

    PubMed  CAS  Google Scholar 

  • Curtis D, Vine AE, Knight J (2008) A simple method for assessing the strength of evidence for association at the level of whole gene. Adv Appl Bioinformatics Chem 1:115–120

    Article  CAS  Google Scholar 

  • Dell’Osso B, Buoli M, Baldwin DS, Altamura AC (2010) Serotonin norepinephrine reuptake inhibitors (SNRIs) in anxiety disorders: a comprehensive review of their clinical efficacy. Hum Psychopharmacol 25(1):17–29

    Article  PubMed  Google Scholar 

  • Erhardt A, Czibere L, Roeske D, Lucae S, Unschuld PG, Ripke S, Specht M, Kohli MA, Kloiber S, Ising M, Heck A, Pfister H, Zimmermann P, Lieb R, Putz B, Uhr M, Weber P, Deussing JM, Gonik M, Bunck M, Kessler MS, Frank E, Hohoff C, Domschke K, Krakowitzky P, Maier W, Bandelow B, Jacob C, Deckert J, Schreiber S, Strohmaier J, Nothen M, Cichon S, Rietschel M, Bettecken T, Keck ME, Landgraf R, Muller-Myhsok B, Holsboer F, Binder EB (2010) TMEM132D, a new candidate for anxiety phenotypes: evidence from human and mouse studies. Mol Psychiatry [Epub ahead of print]

  • Fajas L, Le CL, Polanowska J, Fabbrizio E, Servant N, Philips A, Carnac G, Sardet C (2000) A CDE/CHR-like element mediates repression of transcription of the mouse RB2 (p130) gene. FEBS Lett 471(1):29–33

    Article  PubMed  CAS  Google Scholar 

  • Gordon D, Finch SJ, Nothnagel M, Ott J (2002) Power and sample size calculations for case–control genetic association tests when errors are present: application to single nucleotide polymorphisms. Hum Hered 54(1):22–33

    Article  PubMed  Google Scholar 

  • Gordon D, Levenstien MA, Finch SJ, Ott J (2003) Errors and linkage disequilibrium interact multiplicatively when computing sample sizes for genetic case–control association studies. Pac Symp Biocomput 490–501

  • Hettema JM, Neale MC, Kendler KS (2001) A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatry 158(10):1568–1578

    Article  PubMed  CAS  Google Scholar 

  • Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG (1996) Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl (30) 17–30

  • Kessler RC, Stang PE, Wittchen HU, Ustun TB, Roy-Burne PP, Walters EE (1998) Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 55(9):801–808

    Article  PubMed  CAS  Google Scholar 

  • Kessler RC, Chiu WT, Jin R, Ruscio AM, Shear K, Walters EE (2006) The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication. Arch Gen Psychiatry 63(4):415–424

    Article  PubMed  Google Scholar 

  • Kim TH, Abdullaev ZK, Smith AD, Ching KA, Loukinov DI, Green RD, Zhang MQ, Lobanenkov VV, Ren B (2007) Analysis of the vertebrate insulator protein CTCF-binding sites in the human genome. Cell 128(6):1231–1245

    Article  PubMed  CAS  Google Scholar 

  • Koefoed P, Woldbye DP, Hansen TO, Hansen ES, Knudsen GM, Bolwig TG, Rehfeld JF (2010) Gene variations in the cholecystokinin system in patients with panic disorder. Psychiatr Genet 20(2):59–64

    Article  PubMed  Google Scholar 

  • Kolstad HA, Hansen AM, Kærgaard A, Thomsen JF, Kærlev L, Kristensen AS, Mors O, Mikkelsen S, Grynderup MB, Ruguiles R, Andersen JH, Bonde JP (2011) Job strain and the risk of depression: is reporting biased? Am J Epidemiol 173:94–102

    Article  PubMed  Google Scholar 

  • Kristensen AS, Mortensen EL, Mors O (2008) Social phobia with sudden onset—post-panic social phobia? J Anxiety Disord 22(4):684–692

    Article  PubMed  Google Scholar 

  • Lee YJ, Hohoff C, Domschke K, Sand P, Kuhlenbaumer G, Schirmacher A, Freitag CM, Meyer J, Stober G, Franke P, Nothen MM, Fritze J, Fimmers R, Garritsen HS, Stogbauer F, Deckert J (2005) Norepinephrine transporter (NET) promoter and 5’-UTR polymorphisms: association analysis in panic disorder. Neurosci Lett 377(1):40–43

    Article  PubMed  CAS  Google Scholar 

  • Li Y, Willer C, Sanna S, Abecasis G (2009) Genotype imputation. Annu Rev Genomics Hum Genet 10:387–406

    Google Scholar 

  • Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34:816–834

    Google Scholar 

  • Novembre J, Johnson T, Bryc K, Kutalik Z, Boyko AR, Auton A, Indap A, King KS, Bergmann S, Nelson MR, Stephens M, Bustamante CD (2008) Genes mirror geography within Europe. Nature 456(7218):98–101

    Article  PubMed  CAS  Google Scholar 

  • Otowa T, Yoshida E, Sugaya N, Yasuda S, Nishimura Y, Inoue K, Tochigi M, Umekage T, Miyagawa T, Nishida N, Tokunaga K, Tanii H, Sasaki T, Kaiya H, Okazaki Y (2009) Genome-wide association study of panic disorder in the Japanese population. J Hum Genet 54(2):122–126

    Article  PubMed  CAS  Google Scholar 

  • Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3):559–575

    Article  PubMed  CAS  Google Scholar 

  • Quandt K, Frech K, Karas H, Wingender E, Werner T (1995) MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23(23):4878–4884

    Article  PubMed  CAS  Google Scholar 

  • Sand PG, Mori T, Godau C, Stober G, Flachenecker P, Franke P, Nothen MM, Fritze J, Maier W, Lesch KP, Riederer P, Beckmann H, Deckert J (2002) Norepinephrine transporter gene (NET) variants in patients with panic disorder. Neurosci Lett 333(1):41–44

    Article  PubMed  CAS  Google Scholar 

  • Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4(1):13–25

    Article  PubMed  CAS  Google Scholar 

  • Uher R, Huezo-Diaz P, Perroud N, Smith R, Rietschel M, Mors O, Hauser J, Maier W, Kozel D, Henigsberg N, Barreto M, Placentino A, Dernovsek MZ, Schulze TG, Kalember P, Zobel A, Czerski PM, Larsen ER, Souery D, Giovannini C, Gray JM, Lewis CM, Farmer A, Aitchison KJ, McGuffin P, Craig I (2009) Genetic predictors of response to antidepressants in the GENDEP project. Pharmacogenomics J 9(4):225–233

    Article  PubMed  CAS  Google Scholar 

  • Uher R, Perroud N, Ng MY, Hauser J, Henigsberg N, Maier W, Mors O, Placentino A, Rietschel M, Souery D, Zagar T, Czerski PM, Jerman B, Larsen ER, Schulze TG, Zobel A, Cohen-Woods S, Pirlo K, Butler AW, Muglia P, Barnes MR, Lathrop M, Farmer A, Breen G, Aitchison KJ, Craig I, Lewis CM, McGuffin P (2010) Genome-wide pharmacogenetics of antidepressant response in the GENDEP project. Am J Psychiatry 167(5):555–564

    Article  PubMed  Google Scholar 

  • Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, Nardi A, Savino M (2002) Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry 63(1):31–37

    Article  PubMed  CAS  Google Scholar 

  • Werner T (2000) Computer-assisted analysis of transcription control regions. Mat inspector and other programs. Methods Mol Biol 132:337–349

    PubMed  CAS  Google Scholar 

  • World Health Organization (1993) The ICD-10 classification of mental and behavioural disorders, diagnostic criteria for research

  • World Health Organization (1998) Diagnosis and clinical measurement in psychiatry. A reference manual for SCAN

Download references

Acknowledgments

The authors acknowledge Karina Birk Nygaard, Tracey Flint and Mia Boe Oddershede for excellent technical assistance. The study was supported by the Lundbeck foundation, “TRYG fonden”, “Forskningsfonden til støtte af psykiatrisk forskning i Region Midtjylland”, “Toyota fonden”, Denmark, and the Villum Kann Rasmussen Foundation.

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. N. Buttenschøn.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buttenschøn, H.N., Kristensen, A.S., Buch, H.N. et al. The norepinephrine transporter gene is a candidate gene for panic disorder. J Neural Transm 118, 969–976 (2011). https://doi.org/10.1007/s00702-011-0624-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00702-011-0624-7

Keywords

Navigation